Gossamer Bio · 4 hours ago
Exec Director, Managed Markets & Payer Strategy
Gossamer Bio is committed to shaping and executing payer access strategies to ensure optimal coverage and reimbursement across various channels. The Executive Director will oversee national account directors and manage strategic vendor partnerships while ensuring compliance with legal and regulatory frameworks.
BiotechnologyHealth CareTherapeutics
Responsibilities
Lead the development and execution of national and regional payer access strategies across commercial, Medicare, and Medicaid segments
Define contracting and negotiation strategies with PBMs, MCOs, IDNs, and specialty pharmacies to ensure competitive access and formulary positioning
Partner with Pricing, Trade & Distribution, and Legal/Compliance to design rebate, chargeback, and pricing frameworks aligned with gross-to-net (GTN) targets
Develop payer value propositions, budget impact models, and AMCP dossiers that articulate clinical and economic differentiation
Oversee payer account management, field reimbursement strategy, and customer engagement initiatives
Partner with Marketing and Field Teams to develop payer-focused tools, messaging, and training to support internal and external stakeholders
Ensure all strategies and initiatives align with legal, regulatory, and compliance frameworks
Lead the development of customer segmentation, messaging, and campaign strategies targeting payers, PBMs, and large health systems
Oversee development of HEOR strategy, real-world evidence (RWE) generation, and outcomes-based value demonstration
Oversee compliance with all federal and state pricing programs, including Medicaid, 340B, VA/FSS, and Medicare Part D reporting
Partner with Legal, Compliance, and Finance to ensure accurate calculation of AMP, BP, URA, and ASP in accordance with CMS and OIG requirements
Monitor evolving policy and legislative developments that affect drug pricing, reimbursement, and market access, and provide strategic recommendations to senior leadership
Qualification
Required
Bachelor's degree required; advanced degree (MBA, MPH, MHA, or related field) strongly preferred
15+ years of progressive experience in managed markets/market access within the pharmaceutical or biotech industry
10+ years in a leadership role of people or function
Demonstrated expertise in U.S. payer, reimbursement, and pricing landscapes across both pharmacy and medical benefit channels
Proven success in payer contracting, account management, and policy engagement with Commercial, Medicare, and Medicaid plans
Leadership experience managing account directors and/or market access teams
Cross-functional exposure to HEOR, Sales, Marketing, Regulatory, Finance, and Business Development
Prior experience in vendor selection and management
Strong strategic thinking with the ability to translate corporate vision into tactical execution
Excellent communication and negotiation skills with proven ability to influence senior payer executives and internal leadership
Deep understanding of payer value frameworks, patient access programs, and reimbursement pathways
Strategic, data-driven, and collaborative leader who can balance innovation with compliance rigor
Proficiency in Microsoft Office and ability to quickly adopt new tools and technologies
Position can be based in San Diego, CA or remote
Domestic and occasional international travel required
Company
Gossamer Bio
Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.
H1B Sponsorship
Gossamer Bio has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (2)
2024 (2)
2023 (1)
2021 (4)
Funding
Current Stage
Public CompanyTotal Funding
$812MKey Investors
MidCap FinancialHillhouse Investment
2023-07-20Post Ipo Equity· $212M
2022-07-13Post Ipo Equity· $120M
2019-05-02Post Ipo Debt· $150M
Recent News
XOMA Royalty Corporation
2025-11-14
2025-11-08
2025-11-08
Company data provided by crunchbase